Like last January, infection rates of covid-19 are rising, followed by rising hospital admissions, cancellations of non covid […]

AstraZeneca (AZ) has reported preliminary data from a trial it conducted on its COVID-19 booster shot, Vaxzevria.

Despite diagnosis and treatment options improving for the rare kidney condition, further action is urgently required.

Updated Date: Wed, 05 Jan 2022 00:00:00 EST

Updated Date: Wed, 05 Jan 2022 00:00:00 EST

Updated Date: Wed, 05 Jan 2022 00:00:00 EST

Updated Date: Wed, 05 Jan 2022 00:00:00 EST

Updated Date: Wed, 05 Jan 2022 00:00:00 EST

AstraZeneca sells another half-million doses of its COVID-19 antibody combo to the US fkansteiner Wed, 01/12/2022 – 14:39

Long before the onset of dementia, there is evidence for increased activity of the brain’s immune system. Researchers […]